Retatrutide is one of the most searched research peptides in the Philippines, with demand concentrated in Metro Manila. This guide covers what the compound is, how it compares to related peptides, how the research community sources research-grade material, and what to verify before purchasing. All material referenced here is supplied for research purposes only and is not for human or veterinary use.
what retatrutide is.
Retatrutide (also referenced by the shorthand "reta", and by Lilly's development code LY-3437943) is an investigational triple hormone receptor agonist. A single molecule activates the GLP-1, GIP, and glucagon receptor pathways at once, which is what distinguishes it from single-pathway and dual-pathway compounds. It was developed by Eli Lilly and remains in Phase 3 clinical trials, so it has no regulatory approval anywhere and is not registered with the Philippine FDA. Any retatrutide available in the Philippines outside a clinical trial is research-grade material.
how retatrutide compares to tirzepatide and semaglutide.
Researchers frequently cross-reference these three compounds, so a short comparison helps:
- Semaglutide is a single agonist (GLP-1 only).
- Tirzepatide is a dual agonist (GLP-1 and GIP).
- Retatrutide is a triple agonist (GLP-1, GIP, and glucagon).
The added glucagon-receptor activity is the mechanistic reason retatrutide has drawn heavy interest in the metabolic research literature relative to the earlier two. This section is informational: BodyPharm supplies retatrutide as a research compound and does not stock tirzepatide or semaglutide.
availability in the philippines.
Retatrutide is not stocked by any Philippine pharmacy and has no Mercury Drug or Watsons route, because it is not FDA-registered. Research-grade supply reaches researchers across Metro Manila, Cebu, and Davao through cold-chain delivery. Retatrutide is the most temperature-sensitive of the GLP-class research peptides, so insulated handling matters more here than with most compounds.
The BodyPharm retatrutide Philippines research pen is supplied for laboratory research use only, with a batch-specific Certificate of Analysis.
For the full sourcing picture, see where to buy peptides in the Philippines, covering cold-chain delivery across Metro Manila, Makati, BGC, and Cebu.
verifying research-grade retatrutide.
The single most important check is third-party purity verification. BodyPharm publishes Janoshik laboratory testing per batch so the certificate of analysis can be confirmed independently. In a market where certificates are often reused or circulated without proof of origin, verifiable per-batch testing is the difference between a trustworthy supplier and an unverified one. Always confirm the COA references the actual batch you are receiving before use in any research setting.
cost of research-grade retatrutide in the philippines.
Research-grade retatrutide in the Philippines is supplied at ₱29,199 for a single research pen. Pricing reflects research supply, purity verification, and cold-chain handling, not a therapeutic product.
doses referenced in the research literature.
The published Phase 2 trial (New England Journal of Medicine, 2023) evaluated weekly subcutaneous doses across a titrated range, with the highest study arm reported around 12mg weekly. These figures describe the clinical research protocol and are provided as literature reference only. They are not usage instructions, and this material is not for human use.
frequently asked questions.
Common questions from researchers sourcing retatrutide in the Philippines. Each answer is research-use framed and can be cross-referenced against the linked product page and lab results.
How much does retatrutide cost in the Philippines?
Research-grade retatrutide in the Philippines is supplied at ₱29,199 per research pen. The price reflects purity verification and cold-chain supply for research use.
Is retatrutide available in Manila?
Yes, research-grade retatrutide reaches researchers across Metro Manila, along with Cebu and Davao, via cold-chain delivery. It is not sold in Philippine pharmacies because it is not FDA-registered.
How do I verify retatrutide is genuine?
Confirm the supplier provides third-party (Janoshik) testing tied to the specific batch you receive. BodyPharm publishes per-batch COAs so purity can be verified independently rather than taken on trust.
What doses were used in retatrutide research?
Published trials used titrated weekly subcutaneous doses, with the highest reported study arm around 12mg weekly. This is literature reference only, not a usage instruction.
Is "reta" the same as retatrutide?
Yes. "Reta" is common shorthand for retatrutide in research and community discussion.
Is retatrutide legal or FDA-approved in the Philippines?
Retatrutide is in Phase 3 clinical trials and has no approval from any regulator, including the Philippine FDA. It is supplied strictly as a research compound (research use only), not for human or veterinary use.
Verifying HPLC purity, reading a Certificate of Analysis, and cold-chain delivery across Metro Manila, Makati, BGC, and Cebu.
HPLC-verified retatrutide in the pre-filled research pen format. Batch-specific CoA, secure, trackable, cold-chain delivery.